Can a keto diet starve cancer?

The ketogenic diet: can you starve a cancer?

🩺 Medical review in progress. This page was researched and written from the published studies listed in the sources below. A named medical professional is reviewing it; their sign-off will appear here. Until then, read it as careful homework — and discuss anything you consider with your own doctor.

The bottom line Unknown

The idea — starve the tumor of sugar — sounds compelling, but bodies don't work that simply: yours manufactures its own glucose whatever you eat. The one randomized trial in cancer patients found no delay in tumor growth, and no study anywhere shows keto improves cancer survival. What keto reliably does is cause weight loss — which, for many people with cancer, is exactly the wrong direction.

⚠️ Wrong for anyone losing weight. European oncology nutrition guidelines warn against restrictive diets for patients who are malnourished or losing weight — the diet itself can cause dangerous underfeeding. If your weight is falling, keto can genuinely hurt you.

Here because of a specific diagnosis? This topic appears in our guides to: Glioblastoma

What it is — and the idea behind it

A ketogenic diet cuts carbohydrates so low that the body switches fuel from glucose to fat-derived “ketones”. The cancer logic comes from a real observation (many tumors consume glucose avidly — the “Warburg effect”) plus a leap that doesn't hold: you cannot starve a tumor of glucose through food, because your liver makes glucose around the clock, and tumors are flexible eaters. The lab picture in animals is genuinely mixed — in the mouse work behind the main human trial, keto alone didn't extend survival [1].

What the evidence says

  • Feasibility is shown; benefit is not. The ERGO pilot (20 patients with recurrent glioblastoma) found the diet safe and doable, with “probably no significant clinical activity as a single agent” [1].
  • The one randomized test was negative. ERGO2 randomized 50 patients with recurrent brain tumors to add a calorie-restricted keto diet plus short fasting to re-irradiation: ketosis was achieved, progression-free survival did not improve [2].
  • Reviews agree. A 2026 meta-analysis in glioblastoma: ketosis attainable, survival benefits unproven [4]. An umbrella review of 24 systematic reviews: survival evidence inconclusive; “cannot yet be recommended” [6]. Europe's clinical-nutrition society: no clinical trial demonstrates benefit, and the diet risks underfeeding [7].
  • What keto does do: reliably reduces weight and fat mass [5] — occasionally useful (e.g., some overweight breast-cancer patients under supervision), often hazardous.
  • Compliance is genuinely hard: dropout rates are high in every trial [3][5].

What patients report

Keto has passionate advocates, and some patients feel more in control and less fatigued on it — feelings worth respecting. The honest line: no patient's scan results can be credited to ketosis on current evidence, and several trials were slowed by how hard the diet is to sustain during treatment. Your experience is data we want: .

Safety and interactions

  • Weight loss is near-universal on keto — dangerous with cancer-related weight loss (cachexia) or muscle loss; guidelines advise against energy restriction in anyone at risk of malnutrition [7].
  • Diabetes: on insulin or sulfonylureas, keto can cause serious hypoglycemia — medical supervision is a must.
  • Avoid or supervise closely with kidney stones, liver or pancreas problems, or fat-metabolism disorders; steroid medications (common in cancer care) complicate blood-sugar management further.
  • Expect “keto flu”, constipation, raised cholesterol and uric acid [1][5].

If you still want to try it

Two non-negotiables: your weight must be stable (not falling), and an oncology dietitian must be involved — most cancer centers have one, and the consult is often covered. If those two are true and your team agrees, a supervised trial of keto is a reasonable personal experiment — tracked, time-limited, and abandoned without guilt if weight drops. What it is not, on today's evidence, is a cancer treatment.

Common questions

Does sugar feed cancer — so cutting sugar starves it?

All your cells use glucose, and your liver manufactures it no matter what you eat. No human trial shows a keto diet starves a tumor.

Can keto replace chemo or radiation?

No. It has only been studied alongside standard treatment — and even there, the randomized trial showed no delay in tumor growth.

Is keto safe during treatment?

Only with a dietitian involved and stable weight. If you're losing weight or at risk of malnutrition, it's unsafe.

Didn't keto help brain-cancer patients?

Trials showed it's feasible for motivated patients — but the randomized trial (ERGO2) found no improvement in keeping tumors from progressing.

Sources

  1. TrialRieger J. et al. ERGO: ketogenic diet pilot in 20 patients with recurrent glioblastoma. International Journal of Oncology, 2014. PMC
  2. TrialVoss M. et al. ERGO2: randomized trial of calorie-restricted ketogenic diet + fasting added to re-irradiation in recurrent brain tumors — primary endpoint not improved. Int. J. Radiation Oncology Biology Physics, 2020. redjournal.org
  3. TrialPhase 1 ketogenic diet alongside standard care in newly diagnosed glioblastoma — safety/feasibility. Scientific Reports, 2025. nature.com
  4. ReviewUpdated systematic review and meta-analysis: ketogenic diet in glioblastoma — ketosis attainable, survival benefit unproven. Neurological Sciences, 2026. springer.com
  5. ReviewZhao H. et al. Systematic review/meta-analysis of 10 controlled keto trials in cancer: weight/fat loss, short trials, poor compliance, no survival data. Nutrients, 2022. PMC · Weight-change meta-analysis: Nutrition and Cancer, 2022. PubMed
  6. ReviewUmbrella review of 24 systematic reviews: survival outcomes inconclusive; not recommendable as standard therapy. Integrative Cancer Therapies, 2026. PMC
  7. GuidelineESPEN practical guideline: clinical nutrition in cancer — no demonstrated keto benefit; warns against energy restriction in patients at malnutrition risk. Clinical Nutrition, 2021. clinicalnutritionjournal.com